Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

Autor: Lip, Gregory Y.H., Rasmussen, Lars H., Olsson, S. Bertil, Zetterstrand, Sofia, Stahre, Christina, Bylock, Anders, Aunes-Jansson, Maria, Eriksson, Ulf, Wåhlander, Karin
Zdroj: In Thrombosis Research 2011 127(2):91-99
Databáze: ScienceDirect
Externí odkaz: